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From Science to Guidelines: 
The Future for Resuscitation
ABSTRACT
The periodic development and publication of treatment guidelines is integral to the field of cardiopulmonary resuscitation 
and emergency cardiovascular care.  The methods for guideline development have evolved over the past few decades, and 
the process itself has become the subject of increasing scientific investigation. An internationally validated tool for assessing 
the quality of clinical practice guidelines is The Appraisal of Guidelines for Research and Evaluation (AGREE) instrument. 
Applying this tool to the ILCOR 2010 International Consensus on CPR (cardiopulmonary resuscitation) and ECC (emergency 
cardiac care)  Science with Treatment Recommendations (CoSTR) and the resulting member council guidelines will be a 
valuable initial step in evaluating both the process and the product. By doing so, important strengths can be recognized 
as well as opportunities for improvement moving forward.  Beyond validated tools to assess and improve the quality of the 
traditional guidelines process, a critical reassessment of the overall strategy for improving cardiac arrest outcomes is indi-
cated.  From the lay-provider perspective, innovative approaches to facilitate performance of bystander CPR are needed. 
This is likely to entail more individualized instructional methods that are titrated to the provider’s capabilities for learning 
and performance. What the future might hold for professional providers is a more individualized treatment strategy titrated 
to real-time physiologic monitoring with mechanized delivery of therapies guided by real-time computer-aided medical 
decision-making.  These individualized instructional and treatment strategies could revolutionize our approach to cardiac 
arrest resuscitation, and dramatically change how guidelines are developed, implemented and evaluated.
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Introduction
Periodically updated guidelines have 
been integral to the field of cardiac 
arrest resuscitation  since the first con-
sensus publication of standardized 
treatment recommendations in 1966. 
(1) The first American Heart Associa-
tion (AHA) “standards for resuscita-
tion” were published in 1974, (2) an 
subsequently updated as “guidelines” 
in 1980, 1986, and 1992. The process 
became formally international when 
the International Liaison Committee on 
Resuscitation (ILCOR) published its first 
set of “advisory statements” in 1997. 
(3,4)  In collaboration with the AHA, 
ILCOR produced the first International 
cardiopulmonary resuscitation (CPR) 
Guidelines in 2000 and an International 
Consensus on CPR (cardiopulmonray 
resuscitation) and ECC (emergency 
cardiac care) Science with Treatment 
Recommendations (CoSTR) in 2005.  In 
the fall of 2010, the latest ILCOR CoSTR 
will be published. This consensus docu-
ment will be used by ILCOR member 
councils to develop and disseminate 
their 2010 treatment guidelines.  
Along with advances in the science of 
resuscitation, the process for devel-
oping clinical practice guidelines has 
changed dramatically over that past 44 
years.  In fact, the guidelines develop-
ment process itself has become the 
subject of expanding scientific inves-
tigation.  For resuscitation guidelines 
to have the greatest impact on patient 
outcomes, the science of guideline 
development should be embraced 
along with the science of resuscitation. 
With the latest 5-year cycle of evidence 
evaluation and guideline development 
completed, we have an valuable oppor-
tunity to reflect on the process and 
identify ways to advance the science 
of guideline development in the field 





As mentioned above, the clinical prac-
tice guideline development process 
has become the subject of increasing 
scientific investigation. The Appraisal 
of Guidelines for Research and Evalu-
ation (AGREE) instrument was devel-
oped and published by the AGREE 
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collaboration in 2003. (4)  An updated 
version, AGREE II, was published in 
2010. (5) AGREE is an international-
ly validated appraisal instrument for 
assessing the quality of clinical practice 
guidelines. AGREE II consists of 23 key 
items organized within 6 domains fol-
lowed by 2 global rating items (“Overall 
Assessment”). Each domain captures 
a unique dimension of guideline quality 
(table 1). (6) 
Using AGREE II to assess the 2010 
ILCOR CoSTR and 2010 ILCOR 
member council guidelines will be an 
important initial step in planning for 
the next round of evidence evaluation 
and guideline development.   Overall, 
the process and product is likely to 
score high marks.  Particular strengths 
based on AGREE II criteria are likely to 
be a well-defined scope and purpose, 
the rigor of development, and editorial 
independence as it relates to conflict of 
interest management.  Potential areas 
for improvement include stakeholder 
involvement, clarity of presentation, and 
applicability.  Although relevant profes-
sional disciplines are well-represented 
on ILCOR task forces and the guide-
lines writing groups of member coun-
cils, the opportunity for input from lay 
providers, patients, and patient families 
is limited.  The value of this input is 
becoming increasingly recognized. (7) 
In the clarity of presentation domain, it 
remains challenging to make specific 
and unambiguous recommendations 
in areas where the science is inad-
equate.  A transparent process that 
clearly defines the quality and quantity 
of evidence supporting individual treat-
ment recommendations is essential. 
(8)  Finally, in the applicability domain, 
outlining key review criteria for monitor-
ing and/or audit purposes has not been 
a traditional focus of the CPR and ECC 
guidelines process, despite the availa-
bility of detailed international guidelines 
for reporting clinical research results. 
(9,10)  As a result, limited use of sur-
veillance systems to monitor process 
and outcomes variables in the every 
day management of cardiac arrest 
remains a fundamental barrier to opti-
mizing guideline implementation and 
evaluating the impact new guidelines 
on patient outcomes.
Table 1.  AGREE II Evaluation Criteria.  (6)
Domain Items in Domain
1. Scope and 
purpose
The overall objective(s) of the guideline is (are) specifically described
The clinical question(s) covered by the guideline is (are) specifically described
The patients to whom the guideline is meant to apply are specifically described
2. Stakeholder 
involvement
The guideline development group includes individuals from all relevant professional groups
The patients’ views and preferences have been sought
The target users of the guideline are clearly defined
The guideline has been piloted among end users
3. Rigor of 
development
Systematic methods were used to search for evidence
The criteria for selecting the evidence are clearly described
The methods for formulating the recommendations are clearly described
The health-related benefits, side effects and risks have been considered in formulating the 
recommendations
There is an explicit link between the recommendations and the supporting evidence
The guideline has been externally reviewed by experts prior to its publication
A procedure for updating the guideline is provided
4. Clarity of 
presentation
The recommendations are specific and unambiguous
The different options for management of the condition are clearly presented
Key recommendations are easily identifiable
The guideline is supported with tools for application
5. Applicability
The potential organizational barriers in applying the recommendations have been discussed
The potential cost-related implications of applying the recommendations have been 
considered
The guideline presents key review criteria for monitoring and/or audit purposes
6. Editorial 
independence
The guideline is editorially independent from the funding body
Conflicts of interest of members of the guideline development group have been recorded
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Looking Forward: 
The Future of CPR 
and ECC Guidelines
Moving forward, a critical appraisal of 
the one-size-fits all approach to instruc-
tion and treatment is indicated.  If the 
ultimate goal is for every patient to have 
CPR initiated immediately once cardiac 
arrest is recognized, novel strategies 
are needed to empower the cardiac 
arrest witness to take effective action. 
Traditional CPR training courses con-
tinue to reach a limited audience, and 
both the effectiveness and efficiency of 
this process has come into question. 
Dispatcher assisted CPR, hands-only 
CPR, (11) and smart phone applica-
tions provide examples of innovative 
strategies.  Optimizing these and other 
novel approaches to empower every 
potential cardiac arrest witness to act 
could have dramatic impact on out-of-
hospital cardiac arrest outcomes.  
For the professional provider, the one-
size-fits all approach will eventually be 
recognized as a fundamental barrier 
to improving outcomes.  Standardized 
treatment guidelines and algorithms 
attempt to define care that is opti-
mal for the majority of patients with a 
given presentation. However, the tre-
mendous variability in patients suffer-
ing cardiac arrest suggests that this 
approach might be optimal for only 
a minority of patients.  To overcome 
this barrier, individualized treatment 
strategies titrated to real-time physi-
ologic monitoring will be needed.   This 
approach could be further enhanced 
by mechanized delivery of therapies 
that automatically adjust in real time 
to optimize physiologic parameters. 
Finally real-time computer-aided medi-
cal decision support based on mul-
tiple physiologic parameters might 
also be used to guide management. 
(12)  Optimization of available physi-
ologic monitoring techniques such as 
quantitative waveform capnography, 
VF (ventricular fibrillation)  waveform 
analysis, and ECG filtering to removed 
CPR artifact will provide important ini-
tial steps.  However, novel techniques 
for real-time continuous monitoring 
of organ-specific metabolism during 
CPR, especially for the heart and brain, 
might be the breakthrough needed to 
drive a true paradigm shift.  Once this 
is achieved, an individualized goal-
directed approach to cardiac arrest 
resuscitation could revolutionize the 
way treatment guidelines are devel-
oped, implemented and evaluated.
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